AL
ECL icon

Aspiriant LLC’s Ecolab ECL Stock Holding History

Aspiriant LLC’s Portfolio ECL Stock Details ECL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$399K Sell
1,501
-11
-0.7% -$3.1K 0.01% 247
2025
Q4 		$397K Buy
1,512
+12
+0.8% +$3.2K 0.01% 242
2025
Q3 		$411K Sell
1,500
-291
-16% -$79K 0.01% 217
2025
Q2 		$483K Buy
1,791
+272
+18% +$69.1K 0.02% 202
2025
Q1 		$385K Buy
1,519
+17
+1% +$4.29K 0.01% 212
2024
Q4 		$352K Buy
1,502
+1
+0.1% +$249 0.01% 222
2024
Q3 		$383K Hold
1,501
– – 0.01% 209
2024
Q2 		$357K Sell
1,501
-112
-7% -$25.9K 0.01% 214
2024
Q1 		$372K Sell
1,613
-13
-0.8% -$2.76K 0.02% 228
2023
Q4 		$323K Buy
1,626
+43
+3% +$7.73K 0.01% 229
2023
Q3 		$268K Buy
1,583
+31
+2% +$5.64K 0.01% 239
2023
Q2 		$290K Hold
1,552
– – 0.01% 228
2023
Q1 		$257K Hold
1,552
– – 0.01% 237
2022
Q4 		$226K Buy
1,552
+52
+3% +$7.64K 0.01% 246
2022
Q3 		$217K Sell
1,500
-23
-2% -$3.73K 0.01% 242
2022
Q2 		$235K Buy
1,523
+1
+0.1% +$166 0.01% 241
2022
Q1 		$269K Sell
1,522
-4
-0.3% -$751 0.01% 235
2021
Q4 		$358K Buy
1,526
+20
+1% +$4.52K 0.02% 211
2021
Q3 		$314K Buy
1,506
+1
+0.1% +$219 0.02% 192
2021
Q2 		$310K Buy
1,505
+5
+0.3% +$1.09K 0.02% 197
2021
Q1 		$321K Sell
1,500
-7
-0.5% -$1.49K 0.02% 174
2020
Q4 		$327K Sell
1,507
-4
-0.3% -$836 0.02% 166
2020
Q3 		$302K Buy
1,511
+11
+0.7% +$2.2K 0.02% 181
2020
Q2 		$298K Buy
+1,500
New +$290K 0.03% 155

Other funds holding ECL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Gates Foundation Trust
Gates Foundation Trust Kirkland, Washington $31.7B AUM 20.52% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Aspiriant LLC's ECL Position: Q1 2026 in Review

Aspiriant LLC reduced its Ecolab (ECL) stake by 0.73% in Q1 2026, selling an estimated $3.1K and leaving 1,501 shares worth $399K. The position accounts for 0.01% of the portfolio, ranked #247.

Aspiriant LLC first reported a position in ECL in Q2 2020 and has held it in 24 quarters since. The position peaked at $483K in Q2 2025. 1,691 funds tracked by Wall St. Rank hold ECL as of Q1 2026.

  • Aspiriant LLC held 1,501 shares of Ecolab worth $399K as of Q1 2026.
  • Aspiriant LLC sold 11 Ecolab shares in Q1 2026, an estimated $3.1K.
  • Ecolab made up 0.01% of Aspiriant LLC's portfolio in Q1 2026, its #247 holding.
  • Aspiriant LLC first reported a position in Ecolab in Q2 2020 and has held it in 24 quarters since.
  • Aspiriant LLC's Ecolab position peaked at $483K in Q2 2025.
  • 1,691 funds tracked by Wall St. Rank held Ecolab as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.